Monthly Archives: March 2020

How the EMERGE guideline on medication adherence can improve the quality of clinical trials

Recently, the FDA (Mar 2019) and the EMA (Feb 2020) have finalized guidances to monitor and mitigate the risk of patient non-adherence to the treatments tested in clinical trials. Under the auspices of the International Society for Medication Adherence (ESPACOMP), an … Read More

As the world leader in digital medication adherence monitoring for successful clinical trials, AARDEX is proud to announce its collaboration with 4 Belgian/Swiss financial partners to assist company’s growth.

SRIW, Sowalfin, Noshaq and CCF (Centre de Cautionnement et de Financement du Valais) are now part of the AARDEX Adventure.